Clinical Trials
All Clinical Trials - Page 74 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00001860Phase 2Completed
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
Octreotide
- NCT00003645Phase 3Terminated
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Gonadorelin
- NCT00001849Phase 2Completed
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Octreotide
- NCT01507272Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Male Volunteers
Liraglutide
- NCT00841113Phase 3Completed
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Sermorelin
- NCT00493961Phase 1Completed
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Gonadorelin
- NCT00003283Phase 2Completed
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Octreotide
- NCT01188733Phase 1/Phase 2Completed
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
Octreotide
- NCT00003394Phase 1/Phase 2Completed
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00002779Phase 2Completed
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
Octreotide
- NCT00006368Phase 1Completed
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Octreotide
- NCT00978211Phase 2Completed
DOTA-TOC in Metastasized Neuroendocrine Tumors
Octreotide
- NCT00293670Phase 4Unknown
FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00002967Phase 3Completed
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Octreotide
- NCT00262470Phase 1/Phase 2Active Not Recruiting
Treatment of Orthostatic Intolerance
Octreotide
- NCT00003057Phase 3Completed
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Octreotide
- NCT00615004N/ACompleted
Cardiovascular Outcome After Surgery or Somatostatin Analogues
Octreotide
- NCT00703079N/ACompleted
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Octreotide
- NCT00616408N/ACompleted
Prediction of Tumor Shrinkage in Acromegaly
Octreotide
- NCT00002881Phase 3Completed
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00002947Phase 1Terminated
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Octreotide
- NCT00002864Phase 3Completed
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Octreotide
- NCT00670501Phase 3Completed
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00000380N/ACompleted
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
Sermorelin
- NCT00008073Phase 1Completed
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
Octreotide
- NCT00004363N/ACompleted
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Desmopressin
- NCT00004364N/AUnknown
Study of Novel Types of Familial Diabetes Insipidus
Desmopressin
- NCT00392457N/ACompleted
Investigating the Regulation of Reproductive Hormones in Adult Men
Gonadorelin
- NCT00002651Phase 3Completed
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Gonadorelin
- NCT00461149Phase 4Completed
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Octreotide
- NCT00004327Phase 2Completed
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
Octreotide
- NCT00002597Phase 3Completed
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Gonadorelin
- NCT00004426N/ACompleted
Leuprolide in Determining the Cause of Gonadotropin Deficiency
Gonadorelin
- NCT00004436N/ACompleted
Randomized Study of Hormonal Regulation of Infantile Hemangioma
Gonadorelin
- NCT00002582Phase 3Completed
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Gonadorelin
- NCT00004332N/ACompleted
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
Sermorelin
- NCT00309478Phase 3Completed
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Gonadorelin
- NCT00004311Phase 2Completed
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Gonadorelin
- NCT00001228Phase 2Completed
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Octreotide
- NCT00005006Phase 2Completed
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Teriparatide
- NCT00001190Phase 2Completed
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
Gonadorelin
- NCT07629401N/AAvailable
Pre-approval Expanded Access of Retatrutide (LY3437943)
Retatrutide
- NCT06863363Phase 4Not Yet Recruiting
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
Semaglutide
- NCT00082082Phase 2Completed
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Thymosin-Alpha-1
- NCT00001036Phase 1Completed
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
Thymosin-Alpha-1
- NCT04689360N/AAvailable
An Intermediate Size Expanded Access Protocol of Elamipretide
Elamipretide
- NCT00438217Phase 4Unknown
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Gonadorelin
- NCT01533532Phase 2Completed
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
Gonadorelin
- NCT01395940Phase 2Completed
A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
Gonadorelin
- NCT00767286Phase 3Completed
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Gonadorelin